本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Conduit Pharmaceuticals Inc.

0.0075
-0.0012-13.79%
成交量:406.00
成交額:3.05
市值:- -
市盈率:0.00
高:0.0075
開:0.0075
低:0.0075
收:0.0087
52周最高:0.0217
52周最低:0.0050
股本:- -
流通股本:- -
量比:0.40
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-473.6643
淨資產收益率:--
總資產收益率:--
市淨率:--
市盈率(LYR):- -

資料載入中...

2024/09/14

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/07

重要事件披露

Form 8-K - Current report
2024/09/04

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/08/17

重要事件披露

Form 8-K - Current report
2024/08/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/12

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/07/01

重要事件披露

Form 8-K - Current report
2024/06/01

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/16

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/13

SEC問詢函

Form CORRESP - Correspondence
2023/12/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/01

SEC問詢函

Form CORRESP - Correspondence